{
    "2020-08-31": [
        [
            {
                "time": "",
                "original_text": "“核心+卫星”策略对基金配置有什么意义？",
                "features": {
                    "keywords": [
                        "核心+卫星",
                        "策略",
                        "基金配置"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "中银证券健康产业灵活配置混合基金最新净值涨幅达3.05％",
                "features": {
                    "keywords": [
                        "中银证券",
                        "健康产业",
                        "混合基金",
                        "净值涨幅"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "健康产业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08",
                "original_text": "【国元医药|点评】君实生物2020半年报点评：核心产品快速放量，研发管线进一步推进",
                "features": {
                    "keywords": [
                        "君实生物",
                        "半年报",
                        "核心产品",
                        "研发管线"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08",
                "original_text": "【国元医药|点评】泰格医药2020半年报点评：业务增速逐渐恢复，项目积累进一步增长",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "半年报",
                        "业务增速",
                        "项目积累"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中银创新医疗混合基金最新净值涨幅达2.62%",
                "features": {
                    "keywords": [
                        "中银创新医疗",
                        "混合基金",
                        "净值涨幅"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "48家生物疫苗公司年投120亿研发 市值超2万亿 15家公司股价年内翻倍",
                "features": {
                    "keywords": [
                        "生物疫苗",
                        "研发投入",
                        "市值",
                        "股价翻倍"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}